Nexus NeuroTech Ventures
NE

Nexus NeuroTech Ventures

2023Venture Capital2 portfolioUnited States

About

Founded in 2023 by Jordi Parramon, PhD and William Marks, MD and with the addition of Jon Lundt, PhD, the firm brings a deep commitment to helping those with neurodegenerative, neuropsychiatric, and neurodevelopmental disorders, such as Parkinson’s disease, bipolar disorder, and autism spectrum disorder. Adjacent to these sentinel disorders are many other brain disorders that are also within scope for Nexus NeuroTech Ventures.

Key facts

At-a-glance profile data

Website
nexusneurotech.com
Type
Venture Capital
Headquarters
United States
Portfolio companies
2
Stages
Series B
Series F
Cheque size
$22M to $150M
Sector focus
Healthcare
Autism
Diagnostics
Ultrasound
Therapy

Recent investments

Recent funding rounds Nexus NeuroTech Ventures took part in
DateCompanyRoundAmount
18 Jun 2024InsightecSeries F$150M
2 Apr 2024EarliTec DiagnosticsSeries B$22M
Add first review

Frequently asked

What companies has Nexus NeuroTech Ventures invested in?

Nexus NeuroTech Ventures has invested in Insightec, EarliTec Diagnostics.